08:25 EST Mereo BioPharma (MREO) Group trading halted, news pending
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MREO:
- Regulatory De‑Risking Boosts Setrusumab Outlook and Supports Buy Rating on Mereo BioPharma
- Mereo BioPharma management to meet virtually with Cantor Fitzgerald
- Largest borrow rate increases among liquid names
- Mereo BioPharma’s Q3 2025: Progress in Rare Disease Pipeline
- Positive Outlook for Mereo Biopharma: Buy Rating on Promising Setrusumab Developments and Strong Financial Position